TREST Drug Patent Profile
✉ Email this page to a colleague
When do Trest patents expire, and what generic alternatives are available?
Trest is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in TREST is methixene hydrochloride. Additional details are available on the methixene hydrochloride profile page.
Summary for TREST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Patent Applications: | 965 |
DailyMed Link: | TREST at DailyMed |
US Patents and Regulatory Information for TREST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | TREST | methixene hydrochloride | TABLET;ORAL | 013420-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |